Effect of Shengxuening Tablets Combined with Erythropoietin for the Treatment of Anemia in Premature Infants: An Observation of 60 Cases
- VernacularTitle:生血宁片联合促红细胞生成素治疗早产儿贫血60例临床研究
- Author:
Yunbin CHEN
;
Yanli WANG
;
Weiwei GAO
- Publication Type:Journal Article
- Keywords:
ERYTHROPOIETIN/therapeutic use;
SHENGXUENING TABLETS/therapeutic use;
PREMATURE INFANTS;
ANEMIA/TCM-WM therapy
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2001;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effect of Shengxuening Tablets combined with erythropoietin(EPO) for the treatment of anemia in premature infants.Methods Sixty premature infants aged 31+1 to 32+6 weeks were randomized into two groups.The treatment group received Shengxuening Tablets combined with EPO,and the control group received EPO.The treatment lasted 4 weeks.Before treatment,and 7,14,21 and 28 days after treatment,hemoglobin(Hb) level,hematocrit(HCT),and reticulocyte(Ret) were detected.Meanwhile,the changes of serum ferrum(SF) content and total iron bind capacity(TIBC) before treatment and 14 and 28 days after treatment were observed.Results The cure and markedly effective rate was 96.7% in the treatment group and 80.0% in the control group(P
